Heart Drug for Free Could Save Lives, Money
Study Shows Society Saves Money if Older Patients With Diabetes Get ACE Inhibitor Drugs for Free
WebMD News Archive
July 18, 2005 -- Blood pressure-lowering ACE inhibitor
drugs are among the best weapons available for preventing
life-threatening complications in patients with diabetes, yet far too few of
those patients take them.
Cost is believed to be a big deterrent to ACE inhibitor use, especially among older people
who often have numerous chronic medical problems and take many other
medications. Now a new study suggests that we would all save money
if the 8 million people with diabetes in the U.S. over the age of 65 got the
drugs for free.
Lowering blood pressure with medications has been shown to reduce the risk of heart disease, which is the
major cause of death in people with diabetes. According to the American
Diabetes Association, people with diabetes have a twofold to fourfold increase
in the risk of dying from complications of heart disease.
Researchers concluded that giving ACE inhibitors to older people with
diabetes would financially benefit the Medicare system and society at large.
The blood pressure lowering drugs prevent costly heart attacks, strokes, and
kidney failure in these high-risk patients. People with diabetes should be
treated to attain a blood pressure of less than 130/80.
The cost analysis of the researchers was published in the July 19 issue of
the Annals of Internal Medicine.
"Giving ACE inhibitors to older diabetics at no cost is really a win-win
situation," researcher Allison B. Rosen, MD, MPH, tells WebMD.
"Ensuring that the people who will benefit most are on the medications that
will help save their lives is not just good for the patients, it is good for
the bottom line in terms of getting the most value for our health care
Calculating the Costs
Rosen's research comes as federal officials are set to implement the
Medicare prescription drug coverage plan, which will pay some of the drug costs
for the elderly and disabled.
Even though ACE inhibitors are relatively cheap -- with generic versions of
the drugs costing patients around $250 a year -- Rosen says study after study
has shown that even small out-of-pocket expenses keep many people from taking
the drugs they need.